MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2016 International Congress

    Comparison of the utility of three cognitive scales for MDS Level-I diagnosis of mild cognitive impairment in Parkinson’s disease: MoCA, PD-CRS and ACE-III

    R. Fernandez-Bobadilla, J. Pagonabarraga, J.A. Matias-Guiu, S. Martínez-Horta, A. Horta-Barba, J. Marin-Lahoz, J. Perez-Perez, B. Pascual-Sedano, H. Bejr-Kasem, A. Campolongo, J. Kulisevsky (Barcelona, Spain)

    Objective: To compare the utility for detecting Mild Cognitive Impairment in Parkinson's disease (PD-MCI) of three abbreviated global scales: the Montreal Cognitive Assessment (MoCA), the…
  • 2016 International Congress

    Cytokines in CSF and plasma as potential biomarkers for PD cognitive impairment

    M. Delgado-Alvarado, B. Gago, A. Gorostidi, H. Jiménez-Urbieta, J. Ruiz-Martínez, A. Bergaretxe-Yarza, J.F. Martí-Massó, P. Martínez-Lage, A. Izagirre, A. Oregi, L. Sepúlveda, M.C. Rodríguez-Oroz (San Sebastián, Spain)

    Objective: To assess CSF and plasmatic levels of cytokines as potential biomarkers of PD and PD mild cognitive impairment (PD-MCI). Background: Neuroinflammation may play a…
  • 2016 International Congress

    Participation in cognitively-stimulating activities and computer use are associated with better cognitive performance in Parkinson’s disease independent from nigrostriatal dopaminergic and cortical cholinergic degenerations

    J.L.B. Bohnen, M.L.T.M. Muller, J.D.J. Haugen, N.I. Bohnen (Ann Arbor, MI, USA)

    Objective: To investigate the relationship between times spent with cognitively stimulating activities and cognitive functions in Parkinson's disease (PD) while accounting for the degree of…
  • 2016 International Congress

    The effect of dopamine on global versus specific inhibitory control in Parkinson’s disease

    D. Kuebler, H. Schroll, R. Eva, A. Diepold, C. Meyer, A. Kuhn (Berlin, Germany)

    Objective: To evaluate the effect of dopaminergic medication on inhibitory control using a novel go/no-go task in Parkinson's disease (PD). Global cognition and motor examination…
  • 2016 International Congress

    Consolidation of learning and memory in Parkinson’s disease

    M.E. Sharp, K. Duncan, K. Foerde, R. Kahane, D. Shohamy (New York City, NY, USA)

    Objective: To determine if Parkinson's disease causes an impairment in the ability to consolidate learning into long-term memory and to determine if this deficit is…
  • 2016 International Congress

    Assessment of cognitive-motor interference during an upper extremity motor task in Parkinson’s disease

    P.J.M. Bank, J. Marinus, J.H. de Groot, J.J. van Hilten, C.G.M. Meskers (Leiden, Netherlands)

    Objective: To assess cognitive-motor interference (CMI) and task prioritization during simultaneous performance of a cognitive task and an upper extremity motor task in Parkinson's disease…
  • 2016 International Congress

    Cognitive profile in the Parkinsonian variant of multiple system atrophy: Findings from a Tunisian cohort

    A. Nasri, M. Ben Djebara, I. Kacem, Y. Sidhom, A. Gargouri, R. Gouider (Tunis, Tunisia)

    Objective: To establish the cognitive profile of MSA-P in a Tunisian cohort and to discuss its association with motor signs. Background: It has been previously…
  • 2016 International Congress

    Deep brain stimulation of the globus pallidus interna improves performance in complex oculomotor tasks

    C.A. Antoniades, P. Rebelo, C. Kennard, T. Aziz, A.L. Green, J.J. FitzGerald (Oxford, United Kingdom)

    Objective: To compare and contrast the effects of deep brain stimulation of (a) the subthalamic nucleus and (b) the globus pallidus interna on advanced Parkinson's…
  • 2016 International Congress

    Associations between cerebrospinal fluid proteins and cytokines in Parkinson’s disease

    R. Wijeyekoon, S. Moore, K. Farrell, D. Breen, R. Barker, C.H. Williams-Gray (Cambridge, United Kingdom)

    Objective: To investigate the relationship between cerebrospinal fluid (CSF) proteins and cytokines, and their correlation with clinical measures in PD. Background: Several studies have investigated…
  • 2016 International Congress

    Dynamic dopamine transporter images are helpful for diagnosing parkinsonism

    K. Abe, K. Fukushima, T. Katuura, K. Kitajima, Y. Maeda, K. Hahiskawa, H. Yoshikawa (Nishinomiya, Japan)

    Objective: This study is aimed at introducing a new method to get Dopamine transporter (DAT) imaging simultaneously with regional cerebral flow (CBF) imaging. Background: DAT…
  • « Previous Page
  • 1
  • …
  • 114
  • 115
  • 116
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley